A non-randomized, two-arm, single-sequence, crossover, open label, multiple oral dosing clinical trial to evaluate the safety and the pharmacokinetic drug-drug interaction of Telmisartan/Amlodipine and Rosuvastatin in healthy male volunteers

Inclusion Criteria:

• Healthy male who are ≥19, <50 years old
• Man who weights over 55kg and whose BMI is 18~30(kg/m2)
• Man who doesn't have any chronic disease or history of disease

Exclusion Criteria:

• man who has or had any clinically relevant disease of liver, kidney, nervous/respiratory/musculoskeletal/cardiovascular/hemato-oncology system or neuropsychiatry